Drug Discovery Informatics Market

Collaborations and Partnerships are the Key Growth Strategies Adopted by Market Players in the Drug Discovery Informatics Market

The major players operating in the drug discovery informatics market are IBM (US), Infosys (India), Schrödinger (US), PerkinElmer (US), and Thermo Fisher Scientific (US). The global drug discovery informatics market is expected to reach USD 2.84 Billion in 2022 from USD 1.67 Billion in 2017, to register a CAGR of 11.2%. Rising R&D expenditure and increasing focus on drug discovery are the major factors driving the adoption of discovery informatics solutions.

Most companies focus on collaborations and partnerships to compete in the market. The players also focus on increasing their presence in high-growth markets through agreements, expansions, product launches, and acquisitions. IBM (US), Schrödinger (US), Jubilant Life Sciences (India), and PerkinElmer (US) focus on collaborations to strengthen their position in the market.

IBM’s leading position in the drug discovery informatics market can be attributed to its strong product portfolio and wide geographic presence (spanning the Americas, Europe, and APAC). The company focuses on strengthening its position in the market by adopting organic and inorganic strategies such as expansions, partnerships, and acquisitions. In this regard, in 2016, the company opened The Watson Centre for cognitive solutions in Marina Bay (Singapore). Furthermore, in 2015, the company partnered with Novo Nordisk to conduct research on improved diabetes care utilizing IBM’s Watson Health cognitive computing capabilities. Furthermore, in 2015, IBM acquired Explorys to strengthen its position in the healthcare analytics and cloud computing marketplace.

Schrödinger is one of the prominent players in the drug discovery informatics market. The company enhances its footprints in the market by adopting inorganic growth strategies such as agreements and collaborations. For instance, in 2017, the company collaborated with Petra Pharma to provide drug discovery informatics solutions. In 2016, the company collaborated with Pfizer to develop a computational model for drug discovery.

Some other leading players in the global drug discovery informatics market are Dassault Systèmes (France), Thermo Fisher Scientific (US), Infosys (India), and Selvita (Poland). These companies focus on product launches, expansions, and partnerships to maintain their strong position in the market in the coming years.

Related Reports:

Drug Discovery Informatics Market by Function (Target Data, Sequencing Data Analysis, Molecular Docking, Library Preparation), Solution (Software, Services), End User (Pharmaceutical & Biotechnology, Contract Research Organization) - Global Forecast to 2022

Contact:
Mr. Rohan
MarketsandMarkets™ INC. 
630 Dundee Road 
Suite 430 
Northbrook, IL 60062 
USA : 1-888-600-6441 
sales@marketsandmarkets.com

Report Code
HIT 5838
Published ON
Dec, 2017
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Drug Discovery Informatics Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
REQUEST A FREE WORKSHOP
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
ONLINE CHAT
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
© MarketsandMarkets Research Private Ltd. All rights reserved